Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Melanoma 6Carcinoma, Renal Cell 4Neoplasms 3Neoplasm Metastasis 3Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Hematologic Neoplasms 1Colorectal Neoplasms 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 6Rituximab 6Radiotherapy 6Cyclophosphamide 6Antilymphocyte Serum 6Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Cyclosporine 5Whole-Body Irradiation 4Tacrolimus 4Methotrexate 4Flow Cytometry 4Etoposide 4Cord Blood Stem Cell Transplantation 4Busulfan 4tanespimycin 3romidepsin 3Melphalan 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Gemcitabine 3Bortezomib 3plerixafor 2nelarabine 2mogamulizumab 2cobomarsen 2carfilzomib 2belinostat 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mycosis Fungoides × Introns × Clear all
NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated
100 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡